Robeco BP US Premium Equities D €
Robeco Capital Growth Funds (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis
Fund Profile
Category: SICAV
Robeco BP US Premium Equities is a fund that invests across market capitalizations and sectors in a flexible manner. The selection of these stocks is based on fundamental analysis. The portfolio is consistently built from the bottom up to exhibit attractive valuation, strong business fundamentals and improving business momentum. Investments are predominantly made in securities denominated in US dollars. The fund is denominated in euros. The fund is not constrained by a benchmark. This share class of the fund does not distribute dividend.
Risk and reward profile
6
Lower Risk
Possible Lower
ReturnsHigher Risk
Possible Higher
Returns
Possible Lower
ReturnsHigher Risk
Possible Higher
Returns
Key Information
| Closing Price 18/09/2020 | 359.82 |
| Morningstar category | US Large-Cap Value Equity |
| Currency | EUR |
| Distribution status | Accumulating |
| ISIN | LU0434928536 |
| Inception Date | 13/07/2009 |
| Minimum initial amount | 100.00 EUR |
Fees And Charges
| Entry fee | None |
| Custody fee | None |
| Exit fee | None |
| Ongoing charge | 1.71% of which 0.75% is paid to MeDirect |
Fund management company
| Address | Robeco Luxembourg SA 5, rue Heienhaff L-1736 Senningerberg Luxembourg L-1736 Luxembourg |
| Manager Name | Duilio R. Ramallo |
| Manager Start Date | 03/10/2005 |
| Website | www.robeco.com |
| Total Net Assets (mil) | 3,047.65 EUR (31/08/2020) |
| UCITS | Yes |
| Administrator | J.P. Morgan Bank Luxembourg S.A. |
Documents
Prospectus
| en 01/08/2020 |
KIID
| en 01/08/2020 |
Annual Report
| en 31/12/2019 |
Semi Annual Report
| en 30/06/2019 |
Morningstar Report
| 22/09/2020 |
Performance
Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
| Period | Annualised return | Date |
| 1 year | -11.85% | 18/09/2020 |
| 3 years | 1.25% | 18/09/2020 |
| 5 years | 4.95% | 18/09/2020 |
| 10 years | 10.05% | 18/09/2020 |
| Since launch | 8.40% | 18/09/2020 |
Cumulative performance in EUR
| Performance | |
| YTD 01/01/2020 | -16.88 |
| 1 month | -0.18 |
| 3 months | -0.91 |
| 6 months | 25.83 |
Quarterly Returns
| Q 1 | Q 2 | Q 3 | Q 4 | |
| 2020 | -27.38% | 13.30% | - | - |
| 2019 | 14.47% | 3.59% | 3.89% | 5.73% |
| 2018 | -3.18% | 5.02% | 6.07% | -16.02% |
| 2017 | 3.37% | -3.96% | 0.17% | 3.06% |
| 2016 | -6.55% | 5.73% | 5.06% | 11.78% |
Dividend
Asset Allocation
| % Long | % Short | % Net Assets | |
| Stock | 96.70% | 0.00% | 96.70% |
| Bond | 0.00% | 0.00% | 0.00% |
| Cash | 7.97% | 4.68% | 3.30% |
| Other | 0.00% | 0.00% | 0.00% |
Return/Risk Analysis
| Risk Measurement | 1 Year | 3 Years | 5 Years |
| Standard Deviation | 26.98 | 20.38 | 17.59 |
| Sharpe Ratio | 0.09 | 0.12 | 0.34 |
| Sortino Ratio | 0.11 | 0.15 | 0.46 |
| Positive Months | 6.00 | 22.00 | 33.00 |
| Negative Months | 6.00 | 14.00 | 27.00 |
| Worst Month | -17.90 | -17.90 | -17.90 |
World Regions
| Region | % |
| United States | 89.26 |
| Europe - ex Euro | 3.57 |
| United Kingdom | 1.07 |
| Asia - Developed | 0.90 |
| Asia - Emerging | 0.89 |
| Canada | 0.57 |
| Latin America | 0.44 |
| Eurozone | 0.00 |
Stock Sector Weighting
| Sector | % of Equity |
| Healthcare | 24.11 |
| Financial Services | 22.36 |
| Industrials | 12.95 |
| Technology | 12.92 |
| Consumer Cyclical | 7.92 |
| Communication Services | 6.40 |
| Basic Materials | 5.76 |
| Energy | 2.46 |
| Consumer Defensive | 1.32 |
| Utilities | 0.49 |
Top 10 Holdings
| Holding | Sector | Country | % of Assets |
| Pfizer Inc | Healthcare | United States | 2.12 |
| Bank of America Corp | Financial Services | United States | 2.06 |
| Johnson & Johnson | Healthcare | United States | 2.01 |
| Qorvo Inc | Technology | United States | 1.94 |
| Medtronic PLC | Healthcare | United States | 1.89 |
| JPMorgan Chase & Co | Financial Services | United States | 1.85 |
| Novartis AG ADR | Healthcare | Switzerland | 1.59 |
| Citigroup Inc | Financial Services | United States | 1.50 |
| UnitedHealth Group Inc | Healthcare | United States | 1.48 |
| Oracle Corp | Technology | United States | 1.45 |
Classification of Morningstar Category
| Ranking | 1 Year | 2 Years | 3 Years | 5 Years |
| Top 25% | ||||
| Category above the average | ||||
| Category below the average | ||||
| Bottom 25% |
Morningstar Style Box
Equity Style
Large | Size | |||
Mid | ||||
Small | ||||
Value | Blend | Growth | ||
Style | ||||
€
359.82
Closing Price
All key information and documents must be reviewed before being able to Invest.
© 2019 MeDirect Bank (Malta) plc. All rights reserved.